Serratus Plane Block for Rib Fractures
- Conditions
- Chest TraumaChest Pain
- Registration Number
- NCT03664973
- Lead Sponsor
- Azienda USL Reggio Emilia - IRCCS
- Brief Summary
Patients with ipsilateral multiple rib fractures will be randomized to receive either a single-shot ultrasound-guided serratus plane block, or a continuous serratus plane block within 24h from the chest trauma. Primary outcome is the difference in forced respiratory volume (FEV1) at 72h.
- Detailed Description
Patients admitted in emergency department with a chest trauma and ipsilateral multiple rib fractures, will be randomized as described above. All patients will receive the serratus block with a ropivacaine 0.37% solution 20 ml. Then, they will randomized to receive either a peripheral catheter placed above the 5th rib on the middle axillary line, or nothing. In all patients postoperative analgesia also include Paracetamol 1g IV each 6h and a patient controlled analgesia (PCA) of morphine set out as follow: bolus 1 mg, loch out 15 min, max 4 boluses each hour. In all patients an arterial blood sample for gas analysis and a FEV1 will be achieved before the block, after 1 hour and at 72h.
Recruitment & Eligibility
- Status
- WITHDRAWN
- Sex
- All
- Target Recruitment
- 40
- 2 o more ipsilateral rib fractures
- Trauma within 24h from hospital admission
- Informed consent
- Chest drain
- head trauma
- bilateral rib fractures
- Intensive care admission
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method Pulmonary change function day 0 and day 3 FEV 1
- Secondary Outcome Measures
Name Time Method Morphine day 0, day 1, day 2, day 3, day 4 morphine requirement
Numerical rating scale (NRS) of pain day 0, day 1, day 2, day 3, day 4 Pain both at rest and on movement on a 0-10 scale where 0 is the best and 10 the worst
hospital stay day 1, day 2, day 3, day 4, day 5, day 6, day7 time to fill the discharge criteria
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
Trial Locations
- Locations (1)
AUSL IRCCS Reggio Emilia
🇮🇹Reggio Emilia, Italy
AUSL IRCCS Reggio Emilia🇮🇹Reggio Emilia, Italy